PATH
Menu

This fact sheet provides an overview of PATH's work in developing fast-dissolving tablet vaccine formulations manufactured using a standard lyophilization process. The tablets are packaged in unit-dose blisters, offering an inexpensive, scalable, and easy-to-use presentation for live attenuated vaccines containing single or multiple bacterial strains. Further, the stackable design may minimize product volume and thus the space required for storage and transport, resulting in significant savings for health systems and cold chains.

Corporate author(s): PATH

Publication date: March 2012

Available materials

English

Vaccines in Fast-Dissolving Tablets

305 KB PDF

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Global

See also:

For more information…

Contact: PATH Publications
Email: publications@path.org
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA